Free Trial

BlackRock Capital Allocation Term Trust (NYSE:BCAT) Shares Sold by Rivernorth Capital Management LLC

BlackRock Capital Allocation Term Trust logo with Manufacturing background

Rivernorth Capital Management LLC cut its holdings in BlackRock Capital Allocation Term Trust (NYSE:BCAT - Free Report) by 25.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,498,322 shares of the company's stock after selling 1,208,104 shares during the quarter. BlackRock Capital Allocation Term Trust comprises 2.9% of Rivernorth Capital Management LLC's portfolio, making the stock its 7th largest position. Rivernorth Capital Management LLC owned approximately 3.26% of BlackRock Capital Allocation Term Trust worth $57,547,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of BCAT. Ashton Thomas Securities LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust in the 3rd quarter valued at about $156,000. Walleye Capital LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust during the 3rd quarter worth approximately $234,000. Truist Financial Corp acquired a new stake in BlackRock Capital Allocation Term Trust in the second quarter valued at approximately $319,000. Prospera Financial Services Inc boosted its position in BlackRock Capital Allocation Term Trust by 5.0% in the third quarter. Prospera Financial Services Inc now owns 23,693 shares of the company's stock valued at $390,000 after buying an additional 1,137 shares in the last quarter. Finally, Thrivent Financial for Lutherans acquired a new stake in BlackRock Capital Allocation Term Trust in the third quarter valued at approximately $398,000. 36.12% of the stock is owned by institutional investors.

Insider Buying and Selling

In other BlackRock Capital Allocation Term Trust news, major shareholder Saba Capital Management, L.P. sold 40,158 shares of BlackRock Capital Allocation Term Trust stock in a transaction on Wednesday, October 16th. The shares were sold at an average price of $16.27, for a total value of $653,370.66. Following the completion of the sale, the insider now directly owns 14,969,295 shares of the company's stock, valued at approximately $243,550,429.65. The trade was a 0.27 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold 723,927 shares of company stock valued at $11,925,047 over the last quarter.

BlackRock Capital Allocation Term Trust Price Performance

Shares of NYSE:BCAT traded up $0.02 during mid-day trading on Thursday, reaching $16.29. 160,003 shares of the company's stock were exchanged, compared to its average volume of 354,525. The business's fifty day moving average price is $16.21 and its 200-day moving average price is $16.33. BlackRock Capital Allocation Term Trust has a twelve month low of $14.68 and a twelve month high of $17.18.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently announced a monthly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were paid a dividend of $0.2885 per share. This represents a $3.46 dividend on an annualized basis and a yield of 21.26%. The ex-dividend date of this dividend was Friday, November 15th. This is an increase from BlackRock Capital Allocation Term Trust's previous monthly dividend of $0.10.

BlackRock Capital Allocation Term Trust Company Profile

(Free Report)

-

Further Reading

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Should you invest $1,000 in BlackRock Capital Allocation Term Trust right now?

Before you consider BlackRock Capital Allocation Term Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock Capital Allocation Term Trust wasn't on the list.

While BlackRock Capital Allocation Term Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines